Ars Pharmaceutica impact factor, indexing, ranking (2024)


ars

Aim and Scope

The Ars Pharmaceutica is a research journal published by the Editorial Universidad de Granada. The P-ISSN of this journal is 42927.

Also, please check the following important details about ars pharmaceutica: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.


Important Metrics

Journal Title: Ars Pharmaceutica
Publisher: Editorial Universidad de Granada
P-ISSN: 42927
Open Access:
Status: Inactive
Scopus Coverage: 2003-2017, 1986-2001, 1983-1984, 1980-1981

ars pharmaceutica Indexing

The ars pharmaceutica is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.


Ars Pharmaceutica Impact Factor 2024

The latest impact factor of ars pharmaceutica is N/A.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Publication fee

Based on the Official Journal Homepage, the ars pharmaceutica does not charge any publication fee.

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.


Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the ars pharmaceutica publishes research articles in 10 weeks on an average.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Ars Pharmaceutica?

If your research is related to the scope of the journal, then visit the official website of ars pharmaceutica and send your manuscript.

Tips for publishing in Ars Pharmaceutica:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of ars pharmaceutica is N/A.
  • The ars pharmaceutica is a reputed research journal.
  • It is published by Editorial Universidad de Granada.
  • The journal is indexed in UGC CARE, ESCI, DOAJ.
  • It is an open access journal.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 10 weeks.
  • Based on the Official Journal Homepage, the ars pharmaceutica does not charge any publication fee.

Sources: http://revistaseug.ugr.es/index.php/ars







TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.